person

Daniela P.

Country
Italy
Department
Hematology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
51
Sites with multiple studies

Has run more than one trial at 51 of 133 partner sites.

Specializations

Hematologic Malignancies

This investigator specializes in treating various forms of chronic lymphocytic leukemia (CLL) and its associated conditions. Their research encompasses both previously untreated CLL and cases requiring subsequent therapeutic interventions.

  • CLL/Small Lymphocytic Lymphoma Management
  • Richter's Transformation Treatment
  • Minimal Residual Disease Assessment

Their work extends to investigating novel therapeutic combinations for optimal patient outcomes in hematologic disorders.

Targeted Therapies

The investigator focuses on implementing innovative targeted treatments, including BTK inhibitors and venetoclax-based combinations. Their expertise includes evaluating novel therapeutic approaches for various stages of leukemia.

  • Monoclonal Antibody Therapies
  • B-cell Pathway Inhibition
  • Combination Treatment Strategies

Their research encompasses the development of personalized treatment approaches using targeted therapeutic agents.

Advanced Leukemia Care

The investigator has particular expertise in treating acute B-cell lymphoblastic leukemia and managing patients preparing for hematopoietic stem cell transplantation. Their work includes evaluation of pre-transplant therapeutic strategies.

  • Pre-transplant Treatment Optimization
  • Residual Disease Monitoring
  • Advanced Treatment Protocols

Their focus includes developing effective treatment sequences for complex hematologic conditions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.